课题基金 / 基金详情

Evaluating the use of long-acting antiretroviral treatment for HIV during community re-entry: Addressing community and structural barriers

Evaluating the use of long-acting antiretroviral treatment for HIV during community re-entry: Addressing community and structural barriers
评估重返社区期间艾滋病毒长效抗逆转录病毒治疗的使用情况:解决社区和结构性障碍
批准号:
10818986
负责人:
GEORGIA Doris TOMARAS
金额:
$50.67万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
未结题
起止时间:
2005-04-01 至 2025-06-30

项目摘要

项目成果

GEORGIA Doris TOMARAS的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Abstract Persons who experience incarceration are disproportionately impacted by HIV infection. The time of release from carceral settings, known as community re-entry, is a period of particularly high risk for persons with HIV. During this time, people are at an increased risk of viral rebound due to poor ART adherence, substance use relapse, inability to engage with community HIV providers, inability to fill ART prescriptions, and competing needs in the chaotic environment to which individuals return. Long-acting injectable (LAI) ART is a new alternative to help overcome the challenges of adhering to a daily regimen of oral medication. However, little is known about how best to develop and optimize LAI ART interventions in this population. Therefore, we propose exploratory implementation research that will provide additional preliminary data to enhance our understanding of LAI ART implementation in diverse Ending the HIV Epidemic (EHE) areas in the mid-Atlantic region: Prince Georges County, MD; and Washington, DC. Using the Consolidated Framework for Implementation Research—a theoretical model that guides investigation into the factors that influence implementation, we propose interviewing stakeholders in each of the above EHE areas and conducting a Delphi study. Specific focus will be placed on linkage to a broad array of health services (e.g., mental health, substance use, the need for peer or community health worker services) and the structural barriers that might be present in each location (health insurance, housing, employment, poverty). Our specific aims are to: 1) identify how to optimize future LAI ART interventions in community re-entry populations by interviewing 15 stakeholders at each site (total n=45), and 2) co-produce best practice guidelines for future LAI ART interventions by conducting a Delphi study with 30 experts. The proposed project maps onto the objectives of the funding announcement in that we will conduct implementation research to develop a LAI intervention that addresses multi-level factors that are key to facilitating linkage to innovative HIV treatment modalities. Findings from the supplement supported research will be the foundation of a future R01 application and, importantly, will be shared back with our EHE implementation, governmental, and community partners at each EHE site.
期刊论文(465)
专著(0)
科研奖励(0)
会议论文
DOI: 10.3390/v13050852
发表时间: 2021-05-07
期刊: Viruses
影响因子: --
作者: [Bennett AL, Henderson R]
通讯作者: Henderson R
DOI: 10.3389/fimmu.2021.678511
发表时间: 2021
期刊: Frontiers in immunology
影响因子: 7.3
作者: [Pollara J, Tay MZ, Edwards RW, Goodman D, Crowley AR, Edwards RJ, Easterhoff D, Conley HE, Hoxie T, Gurley T, Jones C, Machiele E, Tuyishime M, Donahue E, Jha S, Spreng RL, Hope TJ, Wiehe K, He MM, Moody MA, Saunders KO, Ackerman ME, Ferrari G, Tomaras GD]
通讯作者: Tomaras GD
DOI: 10.1080/17441692.2021.1951801
发表时间: 2022-12
期刊: Global public health
影响因子: 3.3
作者: [Schmidt CN, Puffer ES, Broverman S, Warren V, Green EP]
通讯作者: Green EP
DOI: 10.1007/s10461-018-2289-9
发表时间: 2019-05
期刊: AIDS and behavior
影响因子: 4.4
作者: [Hightow-Weidman LB, LeGrand S, Muessig KE, Simmons RA, Soni K, Choi SK, Kirschke-Schwartz H, Egger JR]
通讯作者: Egger JR
285
    Impact of Antibody Effector Function Diversity on Antiviral Activity In Situ
    • 批准号:
      10258146
    • 项目类别:
    • 资助金额:
      $434.33万
    • 财政年份:
      2021
    • 负责人:
      GEORGIA Doris TOMARAS
    • 依托单位:
    Mechanisms of Antibody Fc Mediated Protection
    • 批准号:
      10475284
    • 项目类别:
    • 资助金额:
      $59.14万
    • 财政年份:
      2021
    • 负责人:
      GEORGIA Doris TOMARAS
    • 依托单位:
    Administrative Core
    • 批准号:
      10670243
    • 项目类别:
    • 资助金额:
      $25.9万
    • 财政年份:
      2021
    • 负责人:
      GEORGIA Doris TOMARAS
    • 依托单位:
    Antiviral Activity In Situ
    • 批准号:
      10475294
    • 项目类别:
    • 资助金额:
      $85.28万
    • 财政年份:
      2021
    • 负责人:
      GEORGIA Doris TOMARAS
    • 依托单位:
    海外基金